TGA announces SAS Category C for unapproved goods
From July 2017, certain unapproved therapeutic goods can now be supplied immediately to patients without requiring approval by the Therapeutic Goods Administration (TGA), under the new Special Access Scheme (SAS) Category C pathway.
Now practitioners will be able to provide treatments that are deemed to have an established history of use to their patients more efficiently and effectively.
The SAS information on the TGA website have been updated with details of the SAS Category C pathway, including a full list of Category C therapeutic goods and a revised SAS guidance document and forms.
HL Pharma have arranged to stock products to supply through the Category C pathway, please contact us for more information.
< GO BACK